Literature DB >> 16847312

Tissue-specific chromatin modifications at a multigene locus generate asymmetric transcriptional interactions.

Eung Jae Yoo1, Isabela Cajiao, Jeong-Seon Kim, Atsushi P Kimura, Aiwen Zhang, Nancy E Cooke, Stephen A Liebhaber.   

Abstract

Random assortment within mammalian genomes juxtaposes genes with distinct expression profiles. This organization, along with the prevalence of long-range regulatory controls, generates a potential for aberrant transcriptional interactions. The human CD79b/GH locus contains six tightly linked genes with three mutually exclusive tissue specificities and interdigitated control elements. One consequence of this compact organization is that the pituitary cell-specific transcriptional events that activate hGH-N also trigger ectopic activation of CD79b. However, the B-cell-specific events that activate CD79b do not trigger reciprocal activation of hGH-N. Here we utilized DNase I hypersensitive site mapping, chromatin immunoprecipitation, and transgenic models to explore the basis for this asymmetric relationship. The results reveal tissue-specific patterns of chromatin structures and transcriptional controls at the CD79b/GH locus in B cells distinct from those in the pituitary gland and placenta. These three unique transcriptional environments suggest a set of corresponding gene expression pathways and transcriptional interactions that are likely to be found juxtaposed at multiple sites within the eukaryotic genome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16847312      PMCID: PMC1592780          DOI: 10.1128/MCB.00405-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  30 in total

1.  Patterns of histone acetylation suggest dual pathways for gene activation by a bifunctional locus control region.

Authors:  F Elefant; Y Su; S A Liebhaber; N E Cooke
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

2.  Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes.

Authors:  J Kim; S Sif; B Jones; A Jackson; J Koipally; E Heller; S Winandy; A Viel; A Sawyer; T Ikeda; R Kingston; K Georgopoulos
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

Review 3.  Controlling the double helix.

Authors:  Gary Felsenfeld; Mark Groudine
Journal:  Nature       Date:  2003-01-23       Impact factor: 49.962

4.  A defined locus control region determinant links chromatin domain acetylation with long-range gene activation.

Authors:  Yugong Ho; Felice Elefant; Nancy Cooke; Stephen Liebhaber
Journal:  Mol Cell       Date:  2002-02       Impact factor: 17.970

5.  An ikaros-containing chromatin-remodeling complex in adult-type erythroid cells.

Authors:  D W O'Neill; S S Schoetz; R A Lopez; M Castle; L Rabinowitz; E Shor; D Krawchuk; M G Goll; M Renz; H P Seelig; S Han; R H Seong; S D Park; T Agalioti; N Munshi; D Thanos; H Erdjument-Bromage; P Tempst; A Bank
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

6.  Physical linkage of the human growth hormone gene cluster and the CD79b (Ig beta/B29) gene.

Authors:  I M Bennani-Baïti; N E Cooke; S A Liebhaber
Journal:  Genomics       Date:  1998-03-01       Impact factor: 5.736

7.  The human growth hormone gene cluster locus control region supports position-independent pituitary- and placenta-specific expression in the transgenic mouse.

Authors:  Y Su; S A Liebhaber; N E Cooke
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

8.  Epigenetic modifications at the human growth hormone locus predict distinct roles for histone acetylation and methylation in placental gene activation.

Authors:  Atsushi P Kimura; Stephen A Liebhaber; Nancy E Cooke
Journal:  Mol Endocrinol       Date:  2004-01-08

9.  Role for a YY1-binding element in replication-dependent mouse histone gene expression.

Authors:  K A Eliassen; A Baldwin; E M Sikorski; M M Hurt
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

10.  A conserved sequence upstream of the B29 (Ig beta, CD79b) gene interacts with YY1.

Authors:  Lisa Patrone; Sarah E Henson; Randolph Wall; Cindy Sue Malone
Journal:  Mol Biol Rep       Date:  2004-03       Impact factor: 2.316

View more
  7 in total

1.  DNase I hypersensitive site II of the human growth hormone locus control region mediates an essential and distinct long-range enhancer function.

Authors:  Margaret R Fleetwood; Yugong Ho; Nancy E Cooke; Stephen A Liebhaber
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

2.  An RNA-independent linkage of noncoding transcription to long-range enhancer function.

Authors:  Eung Jae Yoo; Nancy E Cooke; Stephen A Liebhaber
Journal:  Mol Cell Biol       Date:  2012-03-19       Impact factor: 4.272

3.  Identification of a secondary promoter within the human B cell receptor component gene hCD79b.

Authors:  Eung Jae Yoo; Nancy E Cooke; Stephen A Liebhaber
Journal:  J Biol Chem       Date:  2013-05-06       Impact factor: 5.157

4.  Human metastatic melanoma cell lines express high levels of growth hormone receptor and respond to GH treatment.

Authors:  Elahu G Sustarsic; Riia K Junnila; John J Kopchick
Journal:  Biochem Biophys Res Commun       Date:  2013-10-14       Impact factor: 3.575

5.  Epigenetic activation of the human growth hormone gene cluster during placental cytotrophoblast differentiation.

Authors:  Atsushi P Kimura; Daria Sizova; Stuart Handwerger; Nancy E Cooke; Stephen A Liebhaber
Journal:  Mol Cell Biol       Date:  2007-07-16       Impact factor: 4.272

6.  Autonomous actions of the human growth hormone long-range enhancer.

Authors:  Eung Jae Yoo; Christopher D Brown; Yu-Cheng Tsai; Nancy E Cooke; Stephen A Liebhaber
Journal:  Nucleic Acids Res       Date:  2015-02-06       Impact factor: 16.971

7.  Long-range looping of a locus control region drives tissue-specific chromatin packing within a multigene cluster.

Authors:  Yu-Cheng Tsai; Nancy E Cooke; Stephen A Liebhaber
Journal:  Nucleic Acids Res       Date:  2016-02-17       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.